Incidence of Acute Lymphocytic Leukemia by County, Children under Age 20, New Mexico, 2017-2021
Indicator Report Data View Options
Incidence of Acute Lymphocytic Leukemia by County, Children under Age 20, New Mexico, 2017-2021
Why Is This Important?
Leukemia is a cancer of the blood-forming cells that affects both adults and children. Leukemia is the most common form of cancer diagnosed in children and adolescents, and often arises very rapidly over a short period of time (acute form). In adults, leukemia is more likely to take many years to develop (chronic form). The causes of leukemia are not well understood but appear to involve a combination of hereditary and environmental factors. Leukemia accounts for around one-quarter of childhood cancers. Acute lymphocytic leukemia accounts for about 75% of childhood leukemia. The five-year survival rate for children under 20 years is 89%.
Definition
Acute lymphocytic leukemia (ALL) incidence refers to the number of persons newly diagnosed with ALL within a specified time period and age group. Measures are calculated for children under age 15 and under age 20. All rates are expressed per 1,000,000 persons.
Data Notes
- Rates have been age-adjusted using the direct method and the 2000 U.S. standard population. For more information on age-adjustment, please visit [https://ibis.doh.nm.gov/resource/AARate.html the NM-IBIS page on age-adjustment].
- **The count or rate in certain cells of the table has been suppressed either because 1) the observed number of events is very small and not appropriate for publication, or 2) it could be us
Data Sources
- New Mexico Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program.
(http://gps.unm.edu/) - New Mexico Tumor Registry
(https://nmtrweb.unm.edu/)
How the Measure is Calculated
Numerator:
The number of ALL cases newly diagnosed in New Mexico residents within a specified time period and age group. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recodes for acute lymphocytic leukemia: 35011. http://seer.cancer.gov/siterecode/Denominator:
The estimated population of New Mexico residents within a specified time period and age group.
Data Issues
New Mexico Population Estimates
{{class RedText NOTE: On January 16, 2025, the NM-IBIS and NMTracking POPULATION ESTIMATES FOR YEARS **2010 THROUGH 2023** WERE REPLACED. Data from the 2020 decennial census were used to update the estimates. Rates calculated using the NM-IBIS and NMTracking web-based queries are affected. Any rates that use population denominators that were calculated after January 16, 2025 will be different from those calculated prior to that date. We apologize for the inconvenience.}} All population estimates apply to July 1 of the selected year. These estimates are considered the most accurate estimates for the state of New Mexico and should match those found on the University of New Mexico [https://gps.unm.edu/pop/population-estimates.html Geospatial and Population Studies website]. Estimates include decimal fractions. Census tract population estimates were summed to produce County estimates. Population estimate totals may vary slightly due to rounding.
New Mexico Tumor Registry
In agreement with the New Mexico Tumor Registry, to ensure confidentiality the count of cancer cases is suppressed for any given county if the count is between one and four and the population is less than 1,000. NOTE: The COVID-19 pandemic disrupted health services, leading to delays and reductions in cancer screening, diagnosis, and reporting to some central cancer registries. This may have contributed to an observed decline in 2020 incidence for most cancer sites.